Ivan Arcari
YOU?
Author Swipe
View article: Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease
Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease Open
Background and Aims Weight loss is an effective therapeutic strategy for patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). This study aimed to identify factors that predict relevant weight loss, defined as at …
View article: Role of artificial intelligence in staging and assessing of treatment response in MASH patients
Role of artificial intelligence in staging and assessing of treatment response in MASH patients Open
Background and Aims The risk of disease progression in MASH increases proportionally to the pathological stage of fibrosis. This latter is evaluated through a semi-quantitative process, which has limited sensitivity in reflecting changes i…
View article: Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases
Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases Open
LINKED CONTENT This article is linked to Thomson et al papers. To view these articles, visit https://doi.org/10.1111/apt.17823 and https://doi.org/10.1111/apt.17877
View article: Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life Open
The introduction of direct-acting antiviral agents (DAAs) into clinical practice has revolutionized the therapeutic approach to patients with chronic hepatitis C virus (HCV) infection. According to the most recent guidelines, the first lin…
View article: Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges
Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges Open
Primary biliary cholangitis and primary sclerosing cholangitis (PSC) are the most common cholestatic liver diseases (CLD) in adults and are both characterized by an immune pathogenesis. While primary biliary cholangitis is a model autoimmu…